PTGS2 and lung cancer: Hunter et al16 previously reported that celecoxib significantly reduced lung toxic effects in mice, suggesting the feasibility of using COX-2 inhibitors to treat radiation-induced lung toxic effects as a complement to concurrent radiation therapy of lung cancers.